Evidence map›Paper›PMID 29030733›Full record

ArticleThe protein journal2017

High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.

Harkiranpreet Kaur Dhaliwal, Nagarajan Thiruvanakarasu, Raj Kumar, Kruti Patel, Ghuncha Ambrin, Shouwei Cai, Bal Ram Singh

Abstract read
In one paragraph

Article in The protein journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Harkiranpreet Kaur DhaliwalBiomedical Engineering and Biotechnology Program, University of Massachusetts Dartmouth, North Dartmouth, MA, 02747, USA.
Nagarajan ThiruvanakarasuDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, MA, 02747, USA.
Raj KumarBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA, 02747, USA.
Kruti PatelDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, MA, 02747, USA.
Ghuncha AmbrinBiomedical Engineering and Biotechnology Program, University of Massachusetts Dartmouth, North Dartmouth, MA, 02747, USA.
Shouwei CaiDepartment of Chemistry and Biochemistry, University of Massachusetts Dartmouth, North Dartmouth, MA, 02747, USA.
Bal Ram SinghBotulinum Research Center, Institute of Advanced Sciences, Dartmouth, MA, 02747, USA. bsingh@inads.org.
University of Massachusetts Dartmouth · USUnited States Food and Drug Administration · US

Funding

Rapid detection of botulinum toxins using a high sensitivity SPR sensorU01AI078070 · NIAID · NEWTON PHOTONICS · PI MELMAN, PAUL · 2009 to 2010
$1.0M
National Institute of Allergy and Infectious Diseases 1U01A1078070-02NIAID NIH HHS U01 AI078070
6 · The paper itself

Abstract

Botulinum neurotoxins (BoNTs) are the most toxic proteins known to cause flaccid muscle paralysis as a result of inhibition of neurotransmitter release from peripheral cholinergic synapses. BoNT type A (BoNT/A) is a 150 kDa protein consisting of two major subunits: light chain (LC) and heavy chain (HC). The LC is required for the catalytic activity of neurotoxin, whereas the C and N terminal domains of the HC are required for cell binding, and translocation of LC across the endosome membranes, respectively. To better understand the structural and functional aspects of BoNT/A intoxication we report here the development of high yield Escherichia coli expression system (2-20-fold higher yield than the value reported in the literature) for the production of recombinant light chain-translocation domain (rLC-TD/A) module of BoNT/A which is catalytically active and translocation competent. The open reading frame of rLC-TD/A was PCR amplified from deactivated recombinant BoNT/A gene (a non-select agent reagent), and was cloned using pET45b (+) vector to express in E. coli cells. The purification procedure included a sequential order of affinity chromatography, trypsinization, and anion exchange column chromatography. We were able to purify > 95% pure, catalytically active and structurally well-folded protein. Comparison of enzyme kinetics of purified LC-TD/A to full-length toxin and recombinant light chain A suggest that the affinity for the substrate is in between endopeptidase domain and botulinum toxin. The potential application of the purified protein has been discussed in toxicity and translocation assays.

Indexed as

Botulinum Toxins, Type AEscherichia coliKineticsMutagenesis, Site-DirectedProtein DomainsRecombinant ProteinsBotulinum Toxins, Type ARecombinant ProteinsBotulinum neurotoxin type ACell-based SNAP-25 assayEnzyme kineticsPotassium channel assayProtein purificationRecombinant light chain-translocation domain rLC-TD/ASite-directed mutagenesisSNAPtide® activityTranslocation

Identifiers

PMID29030733
PMCPMC5705016
OpenAlexW2761811946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.